05-30-2021, 01:28 AM
There are now about 20 randomized clinical trials (RCTs) of ivermectin for covid. They overwhelmingly show reductions in mortality, when used in adequate doses and in patients who are in early enough stages of the disease.
The Kory et al review encompasses both observational and RCT data. It was published in early May in a peer-reviewed journal, the American Journal of Therapeutics, and is already the most-viewed paper in the journal’s history.
https://journals.lww.com/americantherape...the.4.aspx
The Bryant, Lawrie meta analysis is very rigorous (only considers the RCTs etc) and reaches similar conclusions: about a 70% relative reduction in mortality when used in adequate doses and early enough.
https:2.1//osf.io/k37ft/
https://www.youtube.com/watch?v=D2ju5v4TAaQ&t=1166s
The Kory et al review encompasses both observational and RCT data. It was published in early May in a peer-reviewed journal, the American Journal of Therapeutics, and is already the most-viewed paper in the journal’s history.
https://journals.lww.com/americantherape...the.4.aspx
The Bryant, Lawrie meta analysis is very rigorous (only considers the RCTs etc) and reaches similar conclusions: about a 70% relative reduction in mortality when used in adequate doses and early enough.
https:2.1//osf.io/k37ft/
https://www.youtube.com/watch?v=D2ju5v4TAaQ&t=1166s
Finals, then 4 in a row!

